These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 8903182)
1. Helicobacter hepaticus, a recently recognized bacterial pathogen, associated with chronic hepatitis and hepatocellular neoplasia in laboratory mice. Rice JM Emerg Infect Dis; 1995; 1(4):129-31. PubMed ID: 8903182 [No Abstract] [Full Text] [Related]
2. Evaluation of various oral antimicrobial formulations for eradication of Helicobacter hepaticus. Foltz CJ; Fox JG; Yan L; Shames B Lab Anim Sci; 1996 Apr; 46(2):193-7. PubMed ID: 8723236 [TBL] [Abstract][Full Text] [Related]
3. Use of antibiotics to prevent hepatitis and typhlitis in male scid mice spontaneously infected with Helicobacter hepaticus. Russell RJ; Haines DC; Anver MR; Battles JK; Gorelick PL; Blumenauer LL; Gonda MA; Ward JM Lab Anim Sci; 1995 Aug; 45(4):373-8. PubMed ID: 7474875 [TBL] [Abstract][Full Text] [Related]
4. [The treatment of children with Helicobarter pylory by triple therapy can be shortened without the risk of losing it eradicating efficacy. Letter]. Cilleruelo ML; Urruzuno P; Martínez MJ; Madruga D; Sebastián M; Román E; Barrio A; Manzanares J; Medina E; Sarría J; Sanz JC An Esp Pediatr; 1996 Nov; 45(5):550. PubMed ID: 9036795 [No Abstract] [Full Text] [Related]
5. [Role of Helicobacter species in hepatobiliary diseases]. Rasmussen ME; Lauritsen LE; Andersen LP Ugeskr Laeger; 2008 Jun; 170(23):2010-5. PubMed ID: 18534163 [TBL] [Abstract][Full Text] [Related]
6. Six months' experience with a pharmacist-run Helicobacter pylori treatment clinic. Patchin GM; Wieland KA; Carmichael JM Am J Health Syst Pharm; 1996 Sep; 53(17):2081-2. PubMed ID: 8991624 [No Abstract] [Full Text] [Related]
7. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. Ward JM; Fox JG; Anver MR; Haines DC; George CV; Collins MJ; Gorelick PL; Nagashima K; Gonda MA; Gilden RV J Natl Cancer Inst; 1994 Aug; 86(16):1222-7. PubMed ID: 8040890 [TBL] [Abstract][Full Text] [Related]
8. Review of successful treatment for Helicobacter species in laboratory mice. Kerton A; Warden P Lab Anim; 2006 Apr; 40(2):115-22. PubMed ID: 16600071 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a new bismuth-free triple therapy in nude mice and humans. Karita M; Tsuda M; Okita K; Sugiyama T; Nakazawa T Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S31-4. PubMed ID: 8574732 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of antibiotic therapies for eradication of Helicobacter hepaticus. Foltz CJ; Fox JG; Yan L; Shames B Antimicrob Agents Chemother; 1995 Jun; 39(6):1292-4. PubMed ID: 7574518 [TBL] [Abstract][Full Text] [Related]
12. Long-term colonization levels of Helicobacter hepaticus in the cecum of hepatitis-prone A/JCr mice are significantly lower than those in hepatitis-resistant C57BL/6 mice. Whary MT; Cline J; King A; Ge Z; Shen Z; Sheppard B; Fox JG Comp Med; 2001 Oct; 51(5):413-7. PubMed ID: 11924800 [TBL] [Abstract][Full Text] [Related]
14. Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: a multicenter, prospective, randomized, controlled study of efficacy and side effects. Thijs JC; van Zwet AA; Moolenaar W; Wolfhagen MJ; ten Bokkel Huinink J Am J Gastroenterol; 1996 Jan; 91(1):93-7. PubMed ID: 8561152 [TBL] [Abstract][Full Text] [Related]
15. Autoimmunity in chronic active Helicobacter hepatitis of mice. Serum antibodies and expression of heat shock protein 70 in liver. Ward JM; Benveniste RE; Fox CH; Battles JK; Gonda MA; Tully JG Am J Pathol; 1996 Feb; 148(2):509-17. PubMed ID: 8579113 [TBL] [Abstract][Full Text] [Related]
16. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori. Laine L; Estrada R; Trujillo M; Emami S Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755 [TBL] [Abstract][Full Text] [Related]
18. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy. de Boer WA; Haeck PW; Otten MH; Mulder CJ Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338 [TBL] [Abstract][Full Text] [Related]